Focus on 2010 ESC Congress: new ESC guidelines and data on dabigatran.
J
J
Aalbers
D058833:Antithrombin Proteins / Q000008:administration & dosage / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D001562:Benzimidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D003226:Congresses as Topic; D000069604:Dabigatran; D005060:Europe; D006801:Humans; D017410:Practice Guidelines as Topic; D011725:Pyridines / Q000008:administration & dosage / Q000627:therapeutic use*; D020521:Stroke / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use
D058833:Antithrombin Proteins; D001562:Benzimidazoles; D011725:Pyridines; D014859:Warfarin; D000069604:Dabigatran